Hui Yang

7.1k total citations
135 papers, 4.1k citations indexed

About

Hui Yang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Hui Yang has authored 135 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 70 papers in Molecular Biology and 23 papers in Genetics. Recurrent topics in Hui Yang's work include Acute Myeloid Leukemia Research (69 papers), Histone Deacetylase Inhibitors Research (31 papers) and Epigenetics and DNA Methylation (28 papers). Hui Yang is often cited by papers focused on Acute Myeloid Leukemia Research (69 papers), Histone Deacetylase Inhibitors Research (31 papers) and Epigenetics and DNA Methylation (28 papers). Hui Yang collaborates with scholars based in United States, China and Spain. Hui Yang's co-authors include Guillermo Garcia‐Manero, Yue Wei, Hagop M. Kantarjian, Blanca Sánchez‐González, Zeev Estrov, Irene Gañán‐Gómez, Jörge E. Cortes, Stefan Faderl, Jean‐Pierre J. Issa and William G. Wierda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Hui Yang

131 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Yang United States 35 2.7k 1.8k 623 544 535 135 4.1k
Amittha Wickrema United States 38 1.8k 0.6× 1.6k 0.9× 815 1.3× 855 1.6× 740 1.4× 111 3.9k
Jan Jacob Schuringa Netherlands 39 2.1k 0.8× 1.8k 1.0× 918 1.5× 884 1.6× 581 1.1× 147 4.1k
Gang Huang United States 32 2.1k 0.8× 1.4k 0.8× 708 1.1× 412 0.8× 545 1.0× 112 3.5k
Gerwin Huls Netherlands 30 1.9k 0.7× 1.3k 0.7× 749 1.2× 1.1k 2.0× 435 0.8× 115 3.9k
Michael J. Thirman United States 36 2.3k 0.8× 2.4k 1.4× 296 0.5× 559 1.0× 671 1.3× 90 4.0k
Masaharu Akiyama Japan 32 3.2k 1.2× 1.7k 1.0× 781 1.3× 1.3k 2.4× 418 0.8× 90 5.1k
Josée Hébert Canada 33 2.2k 0.8× 947 0.5× 443 0.7× 550 1.0× 257 0.5× 93 3.1k
Véronique Mansat‐De Mas France 25 1.3k 0.5× 1.4k 0.8× 358 0.6× 428 0.8× 546 1.0× 57 2.5k
Ali G. Turhan France 37 1.5k 0.6× 2.0k 1.2× 473 0.8× 1.0k 1.9× 1.4k 2.6× 184 4.0k
Hironori Harada Japan 25 1.9k 0.7× 1.9k 1.1× 328 0.5× 357 0.7× 669 1.3× 110 3.1k

Countries citing papers authored by Hui Yang

Since Specialization
Citations

This map shows the geographic impact of Hui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yang more than expected).

Fields of papers citing papers by Hui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yang. The network helps show where Hui Yang may publish in the future.

Co-authorship network of co-authors of Hui Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yang. A scholar is included among the top collaborators of Hui Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yang. Hui Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Junjie, Hui Yang, Liang Li, Changsi Peng, & Jingying Li. (2025). Noninvasive Transdermal Delivery of STING Agonists Reshapes the Immune Microenvironment of Melanoma and Potentiates Checkpoint Blockade Therapy Efficacy. ACS Applied Bio Materials. 8(4). 3156–3166. 1 indexed citations
2.
Chien, Kelly S., Ziyi Li, Kunhwa Kim, et al.. (2025). Outcomes of hypomethylating agent failure in patients with myelodysplastic syndromes. Blood. 146(Supplement 1). 2075–2075.
3.
Zhang, Yuqi, et al.. (2024). CWF19L1 promotes T-cell cytotoxicity through the regulation of alternative splicing. Journal of Biological Chemistry. 300(12). 107982–107982. 2 indexed citations
4.
Wei, Yue, Hong Zheng, Pamela Lockyer, et al.. (2022). MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia & lymphoma. 63(13). 3154–3164. 1 indexed citations
5.
Li, Jia, Tingting Hong, Yue Wei, et al.. (2022). Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms. Clinical Epigenetics. 14(1). 81–81. 3 indexed citations
6.
Yang, Hui, Guillermo Garcia‐Manero, Koji Sasaki, et al.. (2022). High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance. Leukemia. 36(9). 2306–2316. 61 indexed citations
7.
Carter, Bing Z., Po Yee Mak, Xiangmeng Wang, et al.. (2017). Focal Adhesion Kinase as a Potential Target in AML and MDS. Molecular Cancer Therapeutics. 16(6). 1133–1144. 31 indexed citations
8.
Yang, Hui, Zhihong Fang, Yue Wei, et al.. (2017). Preclinical activity of FF-10501-01, a novel inosine-5′-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia. Leukemia Research. 59. 85–92. 10 indexed citations
9.
Garcia‐Manero, Guillermo, Guillermo Montalban‐Bravo, Hui Yang, et al.. (2016). A Clinical Study of OPN-305, a Toll-like Receptor 2 (TLR-2) Antibody, in Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received Prior Hypomethylating Agent (HMA) Therapy. Blood. 128(22). 227–227. 22 indexed citations
10.
Chamseddine, Ali N., Mónica Cabrero, Yue Wei, et al.. (2016). PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16. S67–S73. 6 indexed citations
11.
Yang, Hui, Andres Quesada, Zachary S. Bohannan, et al.. (2015). Analysis of class I and II histone deacetylase gene expression in human leukemia. Leukemia & lymphoma. 56(12). 3426–3433. 19 indexed citations
12.
Xu, Lihui, Jianhong Zhao, Qiang He, et al.. (2015). Lead Induces Apoptosis and Histone Hyperacetylation in Rat Cardiovascular Tissues. PLoS ONE. 10(6). e0129091–e0129091. 42 indexed citations
13.
Yang, Hui, et al.. (2014). Studies on polyploid induction of different varieties of the colored Zantedeschia hybrid.. Yunnan Nongye Daxue xuebao. 29(2). 229–234. 1 indexed citations
14.
Kuang, Shao-Qing, Zhihong Fang, Patrick A. Zweidler‐McKay, et al.. (2013). Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia. PLoS ONE. 8(4). e61807–e61807. 40 indexed citations
15.
Yang, Hui. (2011). Clinical outcome of bone marrow mesenchymal stem cells transplantation in children with severe cerebral palsy. The Journal of clinical Pediatrics. 2 indexed citations
16.
Garcia‐Manero, Guillermo, Hui Yang, Shao-Qing Kuang, et al.. (2008). Epigenetics of Acute Lymphocytic Leukemia. Seminars in Hematology. 46(1). 24–32. 61 indexed citations
17.
Robinson, Sydney K., Ting Niu, Marcos de Lima, et al.. (2005). Ex vivo expansion of umbilical cord blood. Cytotherapy. 7(3). 243–250. 56 indexed citations
18.
Yang, Hui, Teresa F. Burke, Jack Dempsey, et al.. (2005). Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase. FEBS Letters. 579(16). 3385–3391. 86 indexed citations
19.
Hoshino, Koyu, Hui Yang, Andréia A. Canalli, et al.. (2004). The protein-tyrosine phosphatase SHP1 is downregulated with disease progression in Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML), and effect not mediated by DNA methylation. Cancer Research. 64. 1023–1023. 1 indexed citations
20.
Yang, Hui. (2001). PRELIMINARY STUDY ON INDUCING POLYPLOID IN JAPANESE SCALLOP (PATINOPECTEN YESSOENSIS) BY CYTOCHALASIN B. Dongwu xuebao. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amittha Wickrema Breakdown of academic impact, for papers by Jan Jacob Schuringa Breakdown of academic impact, for papers by Gang Huang Breakdown of academic impact, for papers by Gerwin Huls Breakdown of academic impact, for papers by Michael J. Thirman Breakdown of academic impact, for papers by Masaharu Akiyama Breakdown of academic impact, for papers by Josée Hébert Breakdown of academic impact, for papers by Véronique Mansat‐De Mas Breakdown of academic impact, for papers by Ali G. Turhan Breakdown of academic impact, for papers by Hironori Harada
Rankless by CCL
2026